HEADER CARBOHYDRATE 22-SEP-21 7PRT TITLE CRYSTAL STRUCTURE OF HUMAN HEPARANASE IN COMPLEX WITH COVALENT TITLE 2 INHIBITOR CB678 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPARANASE 50 KDA SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HEPARANASE 8 KDA SUBUNIT; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1; SOURCE 13 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS GLYCOSIDE HYDROLASE, CARBOHYDRATE, GLUCURONIDASE, GH79, HEPARAN KEYWDS 2 SULFATE EXPDTA X-RAY DIFFRACTION AUTHOR L.WU,Z.ARMSTRONG,G.J.DAVIES REVDAT 2 31-JAN-24 7PRT 1 REMARK REVDAT 1 03-AUG-22 7PRT 0 JRNL AUTH C.DE BOER,Z.ARMSTRONG,V.A.J.LIT,U.BARASH,G.RUIJGROK, JRNL AUTH 2 I.BOYANGO,M.M.WEITZENBERG,S.P.SCHRODER,A.J.C.SARRIS, JRNL AUTH 3 N.J.MEEUWENOORD,P.BULE,Y.KAYAL,N.ILAN,J.D.C.CODEE, JRNL AUTH 4 I.VLODAVSKY,H.S.OVERKLEEFT,G.J.DAVIES,L.WU JRNL TITL MECHANISM-BASED HEPARANASE INHIBITORS REDUCE CANCER JRNL TITL 2 METASTASIS IN VIVO. JRNL REF PROC.NATL.ACAD.SCI.USA V. 119 67119 2022 JRNL REFN ESSN 1091-6490 JRNL PMID 35881786 JRNL DOI 10.1073/PNAS.2203167119 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 56910 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.920 REMARK 3 FREE R VALUE TEST SET COUNT : 2800 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4010 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.43 REMARK 3 BIN R VALUE (WORKING SET) : 0.3410 REMARK 3 BIN FREE R VALUE SET COUNT : 198 REMARK 3 BIN FREE R VALUE : 0.3710 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3628 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 117 REMARK 3 SOLVENT ATOMS : 91 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.63900 REMARK 3 B22 (A**2) : -2.88300 REMARK 3 B33 (A**2) : -1.28100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 3.17500 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.105 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.109 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.126 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.445 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.969 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.951 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3890 ; 0.009 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 3647 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5283 ; 1.593 ; 1.676 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8480 ; 1.299 ; 1.603 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 466 ; 6.905 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 182 ;34.159 ;22.033 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 652 ;14.795 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;14.926 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 503 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4264 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 825 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 670 ; 0.214 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 30 ; 0.233 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1896 ; 0.166 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 125 ; 0.132 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1855 ; 2.993 ; 3.824 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1854 ; 2.993 ; 3.822 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2324 ; 4.156 ; 5.722 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2325 ; 4.155 ; 5.725 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2035 ; 3.726 ; 4.357 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2032 ; 3.728 ; 4.350 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2959 ; 5.598 ; 6.361 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2958 ; 5.599 ; 6.359 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 7PRT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-SEP-21. REMARK 100 THE DEPOSITION ID IS D_1292118255. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-FEB-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979524 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 XE 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56984 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 78.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5E98 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES PH 5.5, 0.1 M MGCL2, 17% PEG REMARK 280 3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.81100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19110 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -48.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 155 REMARK 465 PRO A 156 REMARK 465 GLY A 157 REMARK 465 LYS A 158 REMARK 465 LYS A 159 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 428 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 258 74.96 -106.61 REMARK 500 GLU A 343 116.97 -165.57 REMARK 500 LEU A 355 -51.74 -124.55 REMARK 500 LEU A 419 -159.21 -117.80 REMARK 500 ARG A 428 32.87 34.21 REMARK 500 LYS A 430 -27.92 65.88 REMARK 500 LYS A 430 -23.35 64.68 REMARK 500 PRO A 469 40.42 -95.56 REMARK 500 REMARK 500 REMARK: NULL DBREF 7PRT A 158 543 UNP Q9Y251 HPSE_HUMAN 158 543 DBREF 7PRT B 1 74 UNP Q9Y251 HPSE_HUMAN 36 109 SEQADV 7PRT ASP A 155 UNP Q9Y251 EXPRESSION TAG SEQADV 7PRT PRO A 156 UNP Q9Y251 EXPRESSION TAG SEQADV 7PRT GLY A 157 UNP Q9Y251 EXPRESSION TAG SEQADV 7PRT ARG A 307 UNP Q9Y251 LYS 307 VARIANT SEQRES 1 A 389 ASP PRO GLY LYS LYS PHE LYS ASN SER THR TYR SER ARG SEQRES 2 A 389 SER SER VAL ASP VAL LEU TYR THR PHE ALA ASN CYS SER SEQRES 3 A 389 GLY LEU ASP LEU ILE PHE GLY LEU ASN ALA LEU LEU ARG SEQRES 4 A 389 THR ALA ASP LEU GLN TRP ASN SER SER ASN ALA GLN LEU SEQRES 5 A 389 LEU LEU ASP TYR CYS SER SER LYS GLY TYR ASN ILE SER SEQRES 6 A 389 TRP GLU LEU GLY ASN GLU PRO ASN SER PHE LEU LYS LYS SEQRES 7 A 389 ALA ASP ILE PHE ILE ASN GLY SER GLN LEU GLY GLU ASP SEQRES 8 A 389 PHE ILE GLN LEU HIS LYS LEU LEU ARG LYS SER THR PHE SEQRES 9 A 389 LYS ASN ALA LYS LEU TYR GLY PRO ASP VAL GLY GLN PRO SEQRES 10 A 389 ARG ARG LYS THR ALA LYS MET LEU LYS SER PHE LEU LYS SEQRES 11 A 389 ALA GLY GLY GLU VAL ILE ASP SER VAL THR TRP HIS HIS SEQRES 12 A 389 TYR TYR LEU ASN GLY ARG THR ALA THR ARG GLU ASP PHE SEQRES 13 A 389 LEU ASN PRO ASP VAL LEU ASP ILE PHE ILE SER SER VAL SEQRES 14 A 389 GLN LYS VAL PHE GLN VAL VAL GLU SER THR ARG PRO GLY SEQRES 15 A 389 LYS LYS VAL TRP LEU GLY GLU THR SER SER ALA TYR GLY SEQRES 16 A 389 GLY GLY ALA PRO LEU LEU SER ASP THR PHE ALA ALA GLY SEQRES 17 A 389 PHE MET TRP LEU ASP LYS LEU GLY LEU SER ALA ARG MET SEQRES 18 A 389 GLY ILE GLU VAL VAL MET ARG GLN VAL PHE PHE GLY ALA SEQRES 19 A 389 GLY ASN TYR HIS LEU VAL ASP GLU ASN PHE ASP PRO LEU SEQRES 20 A 389 PRO ASP TYR TRP LEU SER LEU LEU PHE LYS LYS LEU VAL SEQRES 21 A 389 GLY THR LYS VAL LEU MET ALA SER VAL GLN GLY SER LYS SEQRES 22 A 389 ARG ARG LYS LEU ARG VAL TYR LEU HIS CYS THR ASN THR SEQRES 23 A 389 ASP ASN PRO ARG TYR LYS GLU GLY ASP LEU THR LEU TYR SEQRES 24 A 389 ALA ILE ASN LEU HIS ASN VAL THR LYS TYR LEU ARG LEU SEQRES 25 A 389 PRO TYR PRO PHE SER ASN LYS GLN VAL ASP LYS TYR LEU SEQRES 26 A 389 LEU ARG PRO LEU GLY PRO HIS GLY LEU LEU SER LYS SER SEQRES 27 A 389 VAL GLN LEU ASN GLY LEU THR LEU LYS MET VAL ASP ASP SEQRES 28 A 389 GLN THR LEU PRO PRO LEU MET GLU LYS PRO LEU ARG PRO SEQRES 29 A 389 GLY SER SER LEU GLY LEU PRO ALA PHE SER TYR SER PHE SEQRES 30 A 389 PHE VAL ILE ARG ASN ALA LYS VAL ALA ALA CYS ILE SEQRES 1 B 74 GLN ASP VAL VAL ASP LEU ASP PHE PHE THR GLN GLU PRO SEQRES 2 B 74 LEU HIS LEU VAL SER PRO SER PHE LEU SER VAL THR ILE SEQRES 3 B 74 ASP ALA ASN LEU ALA THR ASP PRO ARG PHE LEU ILE LEU SEQRES 4 B 74 LEU GLY SER PRO LYS LEU ARG THR LEU ALA ARG GLY LEU SEQRES 5 B 74 SER PRO ALA TYR LEU ARG PHE GLY GLY THR LYS THR ASP SEQRES 6 B 74 PHE LEU ILE PHE ASP PRO LYS LYS GLU HET NAG C 1 14 HET FUC C 2 10 HET 8I4 D 1 13 HET Z61 D 2 10 HET NAG A 601 14 HET NAG A 602 14 HET NAG A 603 14 HET NAG A 604 14 HET EDO A 605 4 HET EDO A 606 4 HET EDO A 607 4 HET CL A 608 1 HET CL A 609 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM 8I4 (2R,3S,5R,6R)-2,3,4,5,6-PENTAKIS(OXIDANYL)CYCLOHEXANE- HETNAM 2 8I4 1-CARBOXYLIC ACID HETNAM Z61 2-DEOXY-ALPHA-D-ARABINO-HEXOPYRANOSE HETNAM EDO 1,2-ETHANEDIOL HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN 8I4 (2R)-5-[(E)-2-(2,4-DINITROPHENYL)ETHENYL]-2-[(1R)-2- HETSYN 2 8I4 OXIDANYL-2-OXIDANYLIDENE-1-(2-THIOPHEN-2- HETSYN 3 8I4 YLETHANOYLAMINO)ETHYL]-3,6-DIHYDRO-2H-1,3-THIAZINE-4- HETSYN 4 8I4 CARBOXYLIC ACID HETSYN Z61 2-DEOXY-ALPHA-D-GLUCOPYRANOSE; 2-DEOXY-ALPHA-D- HETSYN 2 Z61 MANNOPYRANOSE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 NAG 5(C8 H15 N O6) FORMUL 3 FUC C6 H12 O5 FORMUL 4 8I4 C7 H12 O7 FORMUL 4 Z61 C6 H12 O5 FORMUL 9 EDO 3(C2 H6 O2) FORMUL 12 CL 2(CL 1-) FORMUL 14 HOH *91(H2 O) HELIX 1 AA1 SER A 166 SER A 180 1 15 HELIX 2 AA2 SER A 201 LYS A 214 1 14 HELIX 3 AA3 GLU A 225 ASN A 227 5 3 HELIX 4 AA4 SER A 228 ASP A 234 1 7 HELIX 5 AA5 ASN A 238 LYS A 255 1 18 HELIX 6 AA6 ARG A 272 GLY A 287 1 16 HELIX 7 AA7 GLU A 288 ILE A 290 5 3 HELIX 8 AA8 THR A 306 LEU A 311 1 6 HELIX 9 AA9 ASN A 312 ARG A 334 1 23 HELIX 10 AB1 THR A 358 ALA A 360 5 3 HELIX 11 AB2 ALA A 361 GLY A 376 1 16 HELIX 12 AB3 LEU A 401 LEU A 413 1 13 HELIX 13 AB4 HIS A 486 SER A 490 5 5 HELIX 14 AB5 ASN B 29 ASP B 33 5 5 HELIX 15 AB6 ARG B 35 GLY B 41 1 7 HELIX 16 AB7 SER B 42 LEU B 52 1 11 HELIX 17 AB8 GLY B 61 ASP B 65 5 5 SHEET 1 AA1 2 SER A 163 TYR A 165 0 SHEET 2 AA1 2 LEU B 67 PHE B 69 1 O ILE B 68 N SER A 163 SHEET 1 AA2 8 SER A 219 LEU A 222 0 SHEET 2 AA2 8 LEU A 182 LEU A 188 1 N LEU A 188 O GLU A 221 SHEET 3 AA2 8 ALA B 55 GLY B 60 1 O PHE B 59 N ILE A 185 SHEET 4 AA2 8 LEU B 22 ASP B 27 1 N ILE B 26 O ARG B 58 SHEET 5 AA2 8 VAL A 379 ARG A 382 1 N VAL A 380 O SER B 23 SHEET 6 AA2 8 LYS A 338 TYR A 348 1 N LEU A 341 O VAL A 379 SHEET 7 AA2 8 SER A 292 ASN A 301 1 N VAL A 293 O TRP A 340 SHEET 8 AA2 8 TYR A 264 VAL A 268 1 N VAL A 268 O HIS A 296 SHEET 1 AA3 4 LEU A 498 THR A 499 0 SHEET 2 AA3 4 VAL A 493 LEU A 495 -1 N LEU A 495 O LEU A 498 SHEET 3 AA3 4 VAL A 475 PRO A 482 -1 N ARG A 481 O GLN A 494 SHEET 4 AA3 4 LYS A 514 PRO A 515 -1 O LYS A 514 N LYS A 477 SHEET 1 AA4 8 LEU A 498 THR A 499 0 SHEET 2 AA4 8 VAL A 493 LEU A 495 -1 N LEU A 495 O LEU A 498 SHEET 3 AA4 8 VAL A 475 PRO A 482 -1 N ARG A 481 O GLN A 494 SHEET 4 AA4 8 SER A 528 ILE A 534 -1 O VAL A 533 N ASP A 476 SHEET 5 AA4 8 LEU A 450 ASN A 456 -1 N LEU A 452 O PHE A 532 SHEET 6 AA4 8 LEU A 431 THR A 438 -1 N HIS A 436 O THR A 451 SHEET 7 AA4 8 VAL A 414 VAL A 418 -1 N GLY A 415 O CYS A 437 SHEET 8 AA4 8 HIS B 15 LEU B 16 -1 O HIS B 15 N VAL A 418 SHEET 1 AA5 4 MET A 420 VAL A 423 0 SHEET 2 AA5 4 VAL B 3 PHE B 9 -1 O ASP B 7 N SER A 422 SHEET 3 AA5 4 LYS A 462 ARG A 465 1 N ARG A 465 O VAL B 4 SHEET 4 AA5 4 LEU A 522 LEU A 524 -1 O LEU A 522 N LEU A 464 SSBOND 1 CYS A 437 CYS A 542 1555 1555 2.04 LINK ND2 ASN A 162 C1 NAG A 601 1555 1555 1.44 LINK ND2 ASN A 200 C1 NAG A 602 1555 1555 1.47 LINK ND2 ASN A 217 C1 NAG A 603 1555 1555 1.47 LINK ND2 ASN A 238 C1 NAG A 604 1555 1555 1.45 LINK OE2 GLU A 343 C1 8I4 D 1 1555 1555 1.41 LINK ND2 ASN A 459 C1 NAG C 1 1555 1555 1.45 LINK O6 NAG C 1 C1 FUC C 2 1555 1555 1.46 LINK O4 8I4 D 1 C1 Z61 D 2 1555 1555 1.41 CISPEP 1 GLY A 265 PRO A 266 0 1.41 CISPEP 2 GLN A 383 VAL A 384 0 -11.86 CISPEP 3 TYR A 468 PRO A 469 0 -6.88 CISPEP 4 GLY A 484 PRO A 485 0 6.44 CISPEP 5 SER B 53 PRO B 54 0 -2.26 CRYST1 46.808 71.622 78.739 90.00 94.89 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021364 0.000000 0.001829 0.00000 SCALE2 0.000000 0.013962 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012747 0.00000